ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,307Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 52

$673K Total Retail Price of All Prescriptions

Rank: 4 out of 52

510 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

41% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,385 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,447 332 S3 1 3
GABAPENTIN 641 138 2 10
OMEPRAZOLE 508 159 3 6
TRAMADOL HCL 430 50 4 14
SIMVASTATIN 357 166 5 1
LISINOPRIL 344 95 6 2
FUROSEMIDE 313 167 7 7
LEVOTHYROXINE SODIUM 310 151 8 5
NEXIUM 290 46 9 27
DICLOFENAC SODIUM 233 41 10 83
CYCLOBENZAPRINE HCL 182 16 R 11 58
ZOLPIDEM TARTRATE 182 67 11 20
ATENOLOL 178 71 13 17
POTASSIUM CHLORIDE 169 91 14 18
AMLODIPINE BESYLATE 161 73 15 4
METFORMIN HCL 150 42 16 8
METOPROLOL TARTRATE 138 97 17 11
HYDROCHLOROTHIAZIDE 138 54 17 9
ENDOCET 131 17 S2 19 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 21 20 16
RANITIDINE HCL 121 50 21 23
WARFARIN SODIUM 115 109 22 13
METOPROLOL SUCCINATE 114 57 23 15
PROAIR HFA 110 36 24 43
TRICOR 109 0 25 125
ENALAPRIL MALEATE 102 64 26 90
OXYCODONE HCL-ACETAMINOPHEN 100 17 S2 27 55
OXYCODONE HCL 99 19 S2 28 21
CITALOPRAM HBR 98 0 29 28
ADVAIR DISKUS 95 48 30 52
ATORVASTATIN CALCIUM 94 24 31 12
PROMETHAZINE HCL 92 11 R 32 75
CYMBALTA 91 15 33 39
IBUPROFEN 90 28 34 51
TRAZODONE HCL 87 26 35 29
LYRICA 86 18 36 136
PANTOPRAZOLE SODIUM 86 42 36 45
CLOPIDOGREL 84 37 38 36
PRAVASTATIN SODIUM 80 39 39 19
TAMSULOSIN HCL 75 56 40 35
CEFDINIR 74 13 41 143
NAPROXEN 72 31 42 82
CELEBREX 72 12 42 106
AMITRIPTYLINE HCL 70 38 R 44 61
TIZANIDINE HCL 70 13 44 109
SERTRALINE HCL 68 36 46 24
CARISOPRODOL 67 0 R 47 81
FLUOXETINE HCL 66 28 48 64
ALLOPURINOL 65 16 49 32
VYTORIN 65 19 49 145
MELOXICAM 63 21 51 33
PAROXETINE HCL 62 13 52 72
CRESTOR 61 0 53 30
LOSARTAN POTASSIUM 59 39 54 25
MIRTAZAPINE 58 0 55 80
JANUVIA 56 0 56 84
PLAVIX 53 26 57 47
ISOSORBIDE MONONITRATE ER 52 38 58 74
HYDROXYZINE PAMOATE 50 0 R 59 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.